Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects
Author
dc.contributor.author
Quezada Gaon, Natacha
Author
dc.contributor.author
Wortsman, Ximena
Author
dc.contributor.author
Penaloza, Osvaldo
Author
dc.contributor.author
Carrasco, Juan Eduardo
Admission date
dc.date.accessioned
2017-12-21T14:00:19Z
Available date
dc.date.available
2017-12-21T14:00:19Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Journal of Cosmetic Dermatology, 15, 238--244
es_ES
Identifier
dc.identifier.issn
1473-2130
Identifier
dc.identifier.other
10.1111/jocd.12208
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/146236
Abstract
dc.description.abstract
Background Botulinum toxin type A has been used for treating the hypertrophy of the masseter muscles and its cosmetic effects. Ultrasound is increasingly used in dermatology, along with the guidance of mini-invasive procedures.
Aims To evaluate the role of ultrasound for guiding the application of Botulinum A toxin in patients with cosmetic alterations due to bruxism, correlate the clinical landmarks with the ultrasound findings, and study the effect on the symptoms, cosmetics, and quality of life.
Patients/Methods Twenty individuals with bruxism and cosmetic alterations underwent an ultrasound-guided injection of Botulinum toxin type A in each masseter muscle. Clinical and ultrasound marking of the procedure was compared. Clinical and sonographic evaluation was performed at the time of injection and 3 months later. Ten normal individuals underwent ultrasound of the masseter muscles as a control group.
Results Up to 65% of individuals showed anatomical variants of the salivary glands. The method for clinically marking the skin showed a frequently erroneous location of the anterior point (up to 40% of cases) that was proven by ultrasound to be out of the muscle. In 20% of cases, ultrasound showed that the needle should be longer to enter the muscle. After injection, most of the patients demonstrated a decrease of the symptoms and cosmetic and quality of life improvements.
Conclusions Ultrasound can be a potent tool for guiding the injection of Botulinum toxin into the masseter muscles. It may contribute to a more personalized procedure, better cosmetic results, and help to avoid potential complications
Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects
Wortsman, Ximena; Jemec, Gregor B. E.(Springer, 2013)
Significant technological advances have produced equipment that allows imaging of the skin with variable frequency ultrasound in previously unseen detail and provides a range of dynamic data that is currently unmatched by ...
The chalcone and bis-chalcone derivatives have been synthesized under sonication conditions via Claisen-Schmidt condensation with KOH in ethanol at room temperature (20–89%). The structures were established on the basis ...